Form D · Biotechnology
Asana Medical, Inc.
Miami Lakes, FL · CIK 0001625411
Offering snapshot reported Nov 7, 2016 · SEC filing
- Reported sold
- $1.45M Offering amount: $1.45M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Sep 30, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$200,000 → $1,452,460
- Reported investors6 → 19
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2016 | Amendment | $1,452,460 | $1,252,460vs Jul 1, 2015 | 19 | SEC filing |
| Nov 7, 2016 | Initial | $1,452,460 | No comparison | 19 | SEC filing |
| Jul 1, 2015 | Initial | $200,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-242848
The 12% convertible notes and warrant offering was expanded from $750,000 to $1,452,460. These notes were converted in June 2016 to Series A Preferred Shares.
12% Convertible Notes and Warrants Offering
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Nov 7, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Bulman | Director |
| Richard Bulman, Jr. | Executive |
| Gerard S. Coombs | Executive |
| Reginald Hardy | Director |
| Michael Phalen | Director |
| Marc Ramer | Executive |
| Gary Ramphal | Executive |
| Christine Sapan | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6135 Nw 167 Th Street Suite: E 15
Miami Lakes, FL, 33015
Miami Lakes, FL, 33015